PRKAA1 and metabolic dysfunction-associated steatotic liver disease: Investigating how these modifications influence the expression of crucial metabolic regulators, such as SREBPs and AMPK, could provide insights into the molecular underpinnings of MASLD in patients with a history of smoking.